Caligan Partners LP

NEW YORK, NY · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$1.63B2026 Q3
Positions26
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.78.9%

Caligan Partners LP reported 26 positions worth $1.63B as of September 30, 2026 (13F filed November 16, 2026). Largest holding: RVMD (24.6%). Biggest move: exit XENE ($53.7M).

10 / 26 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 RVMDRevolution Medicines$402.7M24.64%1,961,795——-18.7%
▸ 2 LQDALiquidia$245.7M15.03%8,118,892——+89.7%
▸ 3 ABVXAbivax S.A.$154.3M9.44%1,557,924———
▸ 4 PCVXVaxcyte$124.5M7.62%2,188,636——+8.3%
▸ 5 EXELExelixis$90.7M5.55%1,553,262——+14.9%
▸ 6 TNGXTango Therapeutics$62.4M3.82%2,501,246——-3.1%
▸ 7 ADMAAdma Biologics$58.9M3.61%5,875,007——+34.3%
▸ 8 IMCRImmunocore$50.6M3.10%1,672,141———
▸ 9 AVTXAvalo Therapeutics$50.1M3.07%3,268,303——-49.4%
▸ 10 LBRXLB Pharmaceuticals$49.6M3.04%1,509,621———

Pro Feature

The remaining 16 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Caligan Partners LP hold as of Q3 2026?

Caligan Partners LP reported 26 positions worth $1.63B in its Q3 2026 13F filing. Largest positions: RVMD (24.6%), LQDA (15.0%), ABVX (9.4%), PCVX (7.6%) and EXEL (5.6%).

What did Caligan Partners LP buy in Q3 2026?

New positions: OBX, EPRX and TCGX ACQUISITION CORP. Added to: IMCR, FTH, IVA, SGMT and SABS (11 in all).

What did Caligan Partners LP sell in Q3 2026?

Reduced: ARTV and IRD. Sold out entirely: XENE, RVMD, MBX, AGIO and ADMA.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.